Brief: Alphamab Oncology Says Xu Weihao Appointed As CFO
30/03/2021 16:35
March 30 (Reuters) - Alphamab Oncology 9966.HK :
* XU WEIHAO APPOINTED AS CHIEF FINANCIAL OFFICER
Source text for Eikon: urn:newsml:reuters.com:*:nHKScfFHTK
Further company coverage: 9966.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)